Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
McKinsey
Boehringer Ingelheim
Merck
Johnson and Johnson

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Dihydroergotamine mesylate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for dihydroergotamine mesylate and what is the scope of patent protection?

Dihydroergotamine mesylate is the generic ingredient in four branded drugs marketed by Bausch, Hikma Pharms, Paddock Llc, Sagent Pharms Inc, West-ward Pharms Int, and Novartis, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for dihydroergotamine mesylate. Six suppliers are listed for this compound.

Drug Prices for dihydroergotamine mesylate

See drug prices for dihydroergotamine mesylate

Recent Clinical Trials for dihydroergotamine mesylate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Satsuma Pharmaceuticals, Inc.Phase 3
Satsuma Pharmaceuticals, Inc.Phase 1
Impel NeuroPharma Inc.Phase 1

See all dihydroergotamine mesylate clinical trials

Pharmacology for dihydroergotamine mesylate
Medical Subject Heading (MeSH) Categories for dihydroergotamine mesylate
Synonyms for dihydroergotamine mesylate
(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman mesylate
(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman methanesulfonate
(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-Benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxa
(6aR,9R)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
(6aR,9R)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate
(6aR,9R)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate
11032-41-0
511-12-6 (Parent)
6190-39-2
81AXN7R2QT
9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione mesylate
9,10-Dihydroergotamine mesylate
9,10-dihydroergotamine methanesulfonate
910882-41-6
AC1L2FO7
AC1LAOVT
AC1Q6WD6
ADYPXRFPBQGGAH-UMYZUSPBSA-N
AKOS024282478
AN-21195
ANW-42737
C33H37N5O5.CH4O3S
CCG-39548
CHEBI:59756
CHEMBL1200517
CHEMBL1396675
CS-2903
CTK8B3562
D 2763
D.H.E. 45
D02211
D2633
DETMS
DHE-45
Dihydergot
Dihydroergotamine (mesylate)
Dihydroergotamine for peak identification, European Pharmacopoeia (EP) Reference Standard
Dihydroergotamine mesilate
Dihydroergotamine mesilate (JP17)
Dihydroergotamine mesilate, European Pharmacopoeia (EP) Reference Standard
Dihydroergotamine mesylate (USP)
Dihydroergotamine mesylate [USAN:USP]
Dihydroergotamine mesylate [USAN]
Dihydroergotamine mesylate, United States Pharmacopeia (USP) Reference Standard
Dihydroergotamine methanesulfonate
Dihydroergotamine methanesulfonate salt
Dihydroergotamine methanesulfonate salt, powder
Dihydroergotamine monomethanesulfonate
Dihytamine
EINECS 228-235-6
Ergotamine, 9,10-dihydro-, monomethanesulfonate (salt)
Ergotamine, dihydro, methanesulfonate (salt)
Ergotoman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, monomethanesulfonate (salt)
EU-0100357
HMS1920G16
HMS2094K05
HMS2231H03
HMS3261G15
HMS3266C22
HMS3369K10
HMS501N14
HY-B0670A
I14-101170
LP00357
LS-64558
MFCD00058615
mide methanesulfonate
MLS002153175
MLS002207048
MolPort-003-666-163
MT 300
NCGC00261042-01
NSC-759848
NSC759848
Pharmakon1600-01500248
Prestwick_746
rboxamide methanesulfonate(salt)
SCHEMBL40843
SCHEMBL40844
SMR001230668
SPECTRUM1500248
SR-01000075382
SR-01000075382-1
SR-01000075382-3
SR-01000597746
SR-01000597746-1
ST056346
Tox21_500357
TR-021291
TRA0034972
UNII-81AXN7R2QT
Z1544404034

US Patents and Regulatory Information for dihydroergotamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms Inc DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate INJECTABLE;INJECTION 207264-001 Jul 11, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-001 Nov 30, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-002 Nov 30, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma Pharms DIHYDROERGOTAMINE MESYLATE dihydroergotamine mesylate INJECTABLE;INJECTION 206621-001 Sep 15, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for dihydroergotamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997   Start Trial   Start Trial
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997   Start Trial   Start Trial
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Boehringer Ingelheim
Colorcon
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.